27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Gainers
- Liquidia Technologies, Inc. (NASDAQ:LQDA) shares climbed 32.4% to $4.6603 after Wedbush maintained an Outperform rating on the stock.
- NewLink Genetics Corporation (NASDAQ:NLNK) gained 34.6% to $3.1350 on above-average price action. The company announced an exclusive worldwide license with Ellipses Pharma on December 23rd.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares rose 23% to $2.36.
- Clearside Biomedical, Inc. (NASDAQ:CLSD) surged 19.6% to $3.66.
- SilverCrest Metals Inc. (NYSE:SILV) gained 19% to $7.88.
- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) shares jumped 18.1% to $2.8343.
- Can-Fite BioPharma Ltd. (NYSE:CANF) gained 16.8% to $3.48 after the company reported that strategic partnership with Univo to develop cannabinoid-based products is ongoing.
- McDermott International, Inc. (NYSE:MDR) surged 16.7% to $1.2370.
- Proteostasis Therapeutics, Inc. (NASDAQ:PTI) rose 16.4% to $2.6183 after climbing 51.01% on Tuesday.
- Acasti Pharma Inc. (NASDAQ:ACST) gained 15.4% to $2.5502 on a rebound after the stock price dropped on December 23rd after releasing news surrounding its TRILOGY 1 trial.
- Novan, Inc. (NASDAQ:NOVN) shares rose 14.6% to $3.4159.
- SilverSun Technologies, Inc. (NASDAQ:SSNT) shares gained 13.8% to $4.38.
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) surged 12.5% to $3.14.
- Rite Aid Corporation (NYSE:RAD) gained 12.4% to $18.14.
- Technical Communications Corporation (NASDAQ:TCCO) shares gained 12.3% to $5.29 after rising 10.3% on Tuesday.
- Equinox Gold Corp. (NYSE:EQX) gained 11.5% to $7.96.
- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares climbed 9.8% to $6.24.
- Synlogic, Inc. (NASDAQ:SYBX) gained 9.6% to $2.63.
- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares rose 7.5% to $7.09.
- Immunomedics, Inc. (NASDAQ:IMMU) rose 6.7% to $21.86 after the company announced the FDA accepted for filing the company's BLA seeking accelerated approval of sacituzumab govitecan to treat metastatic triple-negative breast cancer.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) shares fell 57.6% to $1.5326 after the company reported that it has stopped dosing of inarigivir patients in Phase 2 program.
- Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares dipped 56.1% to $3.8450 after the company reported that its pre-specified primary endpoint in the Phase 2 Trial of Poziotinib in the previously treated NSCLC was not met in the Cohort 1.
- QIAGEN N.V. (NASDAQ:QGEN) fell 22.4% to $32.18 after the company announced it would not be acquired and it will stay a stand-alone business. Bank of America also reinstated its Underperform rating on the stock and announced a price target of $28 per share.
- Hexo Corp (NYSE:HEXO) dropped 20.7% to $1.5550 after the company reported $25 million offering of 14.97 million shares at $1.67 per share.
- Microbot Medical Inc. (NASDAQ:MBOT) fell 17% to $13.52 after climbing 61.03% on Tuesday. Microbot Medical, which recently unveiled a fully disposable robotic system for endovascular procedures, said it has entered into definitive agreements with certain institutional investors for the sale of 912,858 shares in a registered direct offering at a purchase price of $10.50, priced at-the-market under Nasdaq rules.
- Cassava Sciences, Inc. (NASDAQ:SAVA) fell 14.5% to $3.89 after surging 26.74% on Tuesday.
- PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) shares declined 11.7% to $6.49 after surging 12.3% on Tuesday.
- Harpoon Therapeutics, Inc. (NASDAQ:HARP) fell 10.1% to $18.51.
- Seadrill Limited (NYSE:SDRL) shares declined 9.5% to $2.49.
- CLPS Incorporation (NASDAQ:CLPS) dropped 9.4% to $5.80 after climbing 46.1% on Tuesday.
- TravelCenters of America Inc. (NASDAQ:TA) dipped 9% to $17.11.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) tumbled 7.2% to $3.75.
- Repro Med Systems, Inc. (NASDAQ:KRMD) dropped 6.7% to $5.90.
- NIO Limited (NYSE:NIO) fell 5.5% to $2.39 after dropping 5.24% on Tuesday. NIO will report Q3 earnings next week on Monday, Dec. 30, 2019 before the market opens.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.